Balloon pulmonary angioplasty versus riociguat in inoperable chronic thromboembolic pulmonary hypertension (MR BPA): an open-label, randomised controlled trial
The Lancet Respiratory Medicine(2022)
摘要
For the Japanese translation of the abstract see Supplementary Materials section.
更多查看译文
关键词
pulmonary hypertension,inoperable chronic thromboembolic,mr bpa,open-label
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要